Cymbalta and Sialoadenitis - a phase IV clinical study of FDA data

Summary:

Sialoadenitis is reported as a side effect among people who take Cymbalta (duloxetine hydrochloride), especially for people who are female, 40-49 old, also take Symbicort, and have Asthma.

The phase IV clinical study analyzes which people have Sialoadenitis when taking Cymbalta. It is created by eHealthMe based on reports of 145,249 people who have side effects when taking Cymbalta from the FDA, and is updated regularly.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,973 Cymbalta users. Check the latest studies of Cymbalta.

What is Sialoadenitis?

Sialoadenitis (inflammation of a salivary gland) is found to be associated with 342 drugs and 329 conditions by eHealthMe. Check the latest studies of Sialoadenitis.

On Jul, 27, 2026

145,249 people reported to have side effects when taking Cymbalta.
Among them, 20 people (0.01%) have Sialoadenitis.

Among these 20 people:

What is the gender of people who have Sialoadenitis when taking Cymbalta? *

female: 94.74 %
male: 5.26 %

What is the age of people who have Sialoadenitis when taking Cymbalta? *

What are other drugs people take besides Cymbalta? *

What are other side effects people have besides Sialoadenitis? *

Sinusitis (inflammation of sinus): 13 people, 65.00%
High Blood Pressure: 13 people, 65.00%
Osteomyelitis (infection of bone): 12 people, 60.00%
Viral Infection: 10 people, 50.00%
The Flu (the flu is caused by an influenza virus): 9 people, 45.00%
Injection Site Swelling: 9 people, 45.00%
Injection Site Pallor (an unhealthy pale appearance at injection site): 9 people, 45.00%
Injection Site Pain: 9 people, 45.00%
Weight Increased: 8 people, 40.00%
Oedema Peripheral (superficial swelling): 8 people, 40.00%

What are the existing conditions these people have? *

Asthma: 10 people, 50.00%
Dyspnea (difficult or laboured breathing): 4 people, 20.00%
Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 15.00%
Weight Decreased: 3 people, 15.00%
Pain: 2 people, 10.00%
Neuralgia (pain in one or more nerves): 2 people, 10.00%
Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 2 people, 10.00%
High Blood Pressure: 2 people, 10.00%
Swelling: 1 person, 5.00%
Indigestion: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cymbalta and have Sialoadenitis?

- Check whether Sialoadenitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cymbalta:

Cymbalta (154,973 reports)

Sialoadenitis treatments and more:

Sialoadenitis (1,917 reports)

Browse all side effects of Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sialoadenitis:

Sialoadenitis (342 drugs)

Browse all the conditions that are associated with Sialoadenitis:

Sialoadenitis (329 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on duloxetine hydrochloride (the active ingredients of Cymbalta) and Cymbalta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.